Trudeau government under fire for failing Canadians suffering serious COVID vaccine complications
Stories of the claimants
Even those approved remain frustrated
(You can now subscribe to our
(You can now subscribe to our Economic Times WhatsApp channel
A Canadian program designed to compensate people seriously injured by COVID-19 vaccines is facing growing criticism from claimants who say they've been abandoned, ignored, and denied basic support.The largest immunization campaign in Canadian history helped curb the spread of COVID-19, saving thousands of lives and easing pressure on overcrowded emergency rooms. For the vast majority, vaccines marked the beginning of a return to normal life.But for a small group who suffered serious side effects, life has never been the same.Launched in 2021 by then-prime minister Justin Trudeau with a $50 million budget, the Vaccine Injury Support Program ( VISP ) was established to provide financial assistance to individuals who suffered permanent, serious harm after receiving a Health Canada-authorized vaccine. The program offers lump-sum payments, income replacement, and medical expense reimbursement.But an investigation reveals that VISP is falling far short of its promise.Of the $50.6 million spent to date, $33.7 million went to administration, while just $16.9 million reached injured Canadians. More than 3,000 claims have been submitted, but 1,700 are still waiting for a decision.Kayla Pollock, a former kindergarten assistant from Ontario, was diagnosed with transverse myelitis, a serious spinal condition, after vaccination. She now uses a wheelchair. Pollock submitted her VISP application in July 2022. It was lost. Three years later, her case is still in 'intake.''It costs me more to be alive than if I were dead,' she said.Other claimants shared similar experiences. Shannon Dupont, a Manitoba social worker, suffered a stroke and Bell's palsy after vaccination. She's had nine case managers, cashed out investments, and says she's owed $180,000.Mike Becker was hospitalized with blood clots nine days after his shot. VISP denied his claim, citing missing platelet data. His appeal was mistakenly closed and ignored for nearly two years.Ross Wightman, diagnosed with Guillain-Barré syndrome, received $270,000 in 2022. But he waited 20 months for income replacement, and says VISP's poor communication left him relying on 'the bank of family.'VISP was outsourced to private firm Oxaro Inc., which initially expected just 40 claims per year. Critics say the system wasn't prepared for the volume or complexity of real-world cases.Health Minister Marjorie Michel called the reports 'completely unacceptable,' and said her office has asked the Public Health Agency of Canada (PHAC) to review the program's operations. 'All options are on the table,' she said.Medical experts, including Dr. Kumanan Wilson, had warned the government not to create the program mid-pandemic. 'You don't want to stand these things up during an emergency,' he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Pharma rivals unite to back Made-in-India vaccines
NEW DELHI: Pharma promoters may be competing fiercely in the market, but on Thursday they all rallied behind domestically- manufactured vaccines, including those for polio and Covid-19. Satish Reddy, chairman of Dr Reddy's Laboratories, Dilip Shanghvi, promoter and CMD of Sun Pharma, Pankaj Patel chairman and promoter of Zydus Lifesciences, and Torrent Pharma chairman Samir Mehta —industry leaders known for their media reticence—each took to social media platforms to endorse India-made vaccines. These comments come amid rising concerns over sudden deaths in Karnataka, and claims that Covid-19 vaccines might be associated with heart attacks. In separate posts, they highlighted that these vaccines are safe, effective, and trusted in over 90 countries, backed by the World Health Organization (WHO), and widely used across the globe. India accounts for 60% of global vaccine production. During the Covid pandemic, vaccines played a crucial role, and India supplied vaccines and critical medicines across the world. Linking the deaths to the COVID-19 vaccine without any scientific evidence is incorrect and misleading, they added. ``They helped end polio & fight COVID. At a time when India is seen as a vaccine leader, let's build trust in science, not doubt it. Public health must stay above politics'', Reddy said in a post on micro-blogging site, X. Interestingly, all comments were posted on the same day, which is unprecedented. Patel said on X ``There are other multiple reasons like age, environmental factors, genetics, lifestyle etc, that could be the leading cause of heart attacks in people. Several scientific studies globally and in India have conclusively shown that the risk of heart attack or myocarditis is greater after SARS-CoV-2 infection. It has been proven beyond doubt that vaccination remains the most effective and preventive healthcare strategy to reduce deaths and disabilities''. ``The vaccine has been administered to millions across the country. If there were a connection, we would have seen similar incidents in many other places - which is not the case. The state health authorities should thoroughly investigate the situation to determine the cause'', Shanghvi stated in a Linkedin post. Batting for the ``knowledge-driven sector which plays a vital role in global health'', Indian Pharmaceutical Alliance secretary general Sudarshan Jain said ``Misinformation and distortion of facts endanger public health and undermine the trust built on science and patient care globally''. Further, Biocon chairperson Kiran Mazumdar-Shaw said in a post on X that COVID-19 vaccines developed in India were approved, following ``rigorous protocols''. She debunked Karnataka chief minister Siddaramaiah's view which linked heart-related deaths in Hassan to Covid vaccine. O n July 1, he had said "hasty approval and distribution" of the vaccine to the public could also be a reason for the multiple deaths. UK major AstraZeneca had also licensed Pune-based Serum Institute of India to manufacture the Covid-19 vaccine, which was sold as Covishield in the country. It was also shipped to several countries as part of the govt's `Vaccine Maitri' initiative. Earlier, the health ministry said that extensive studies by the Indian Council of Medical Research and All India Institute of Medical Sciences have conclusively established no linkage between COVID-19 vaccines, and sudden deaths among adults post-COVID-19.
Indian Express
an hour ago
- Indian Express
No link between Covid vaccine and sudden cardiac arrest in young people: AIIMS Delhi study finds
There is no link between the Covid-19 vaccine and deaths in young people from cardiac arrest, claimed an ongoing study being conducted by AIIMS, New Delhi. These deaths were attributed to coronary artery disease (CHD) linked to poor lifestyle choices. These preliminary findings are part of an interim report based on a study, titled 'Establishing the cause in sudden unexplained deaths in young', which AIIMS is conducting in collaboration with the Indian Council of Medical Research. On Thursday, doctors involved in the study said the cause of death among the young population was CHD. Addressing the risk factor around Covid vaccination, Dr Sanjay Rai, Professor of Community Medicine, said there was a huge benefit from vaccination. 'A certain risk is always present, which is why we do a risk and benefit analysis before starting any vaccination,' he added. Dr Rai was the principal investigator of the vaccine safety (phases 1 & 2) and effectiveness (phase 3) trial at AIIMS. Dr Abhishek Yadav, Professor of Forensic Medicine, said the study began in 2023 with a sample size of 300 medico-legal cases of sudden deaths. Post-mortems in these cases were conducted in the AIIMS Forensic Medicine Department. 'These were people between the ages of 18 and 45 years and 45 and 60 years… almost all of them had taken the Covid vaccine,' he said. Dr Sudheer Arava, Professor, Department of Pathology, who was involved in the study, said the biggest problem was coronary artery disease — more than 50% of those who died of the disease had a history of alcohol consumption and smoking. Almost all of them had evidence of the Covid-19 vaccine — either a single, double or booster dose. Explaining how they arrived at the findings, Dr Yadav said, 'These were people between the ages of 18 and 45 years and 45 and 60 years… almost all of them had taken the Covid vaccine. We first did a verbal autopsy where we noted down the patient's detailed history, stress, habits, etc. We then did a virtual autopsy and later a traditional autopsy, where we investigated every organ in the body. We then did a histopathological analysis of organs with the help of microscopy.' 'We examined every organ along with the forensic department and did whole body scans, whole body examinations… So any of the secondary causes we would have picked up might have caused the death of these people,' added Dr Arava. Dr Arava further said two-thirds of cardiovascular causes were atherosclerosis (plaque buildup inside the arteries). 'The less common causes were congenital heart problems, the heart vessels not being straight, the original vessels being small, and heart infections. All these problems were in less than 5% of the total sample size,' he added. He further said, looking at the pattern of deaths, there is no difference between the pre-Covid era and the post-Covid era. 'Vaccination has no role to play. The sudden deaths were happening pre-Covid too. The only thing that changed is that we have become more aware.' Dr Ambuj Roy, Professor, Cardiology, who was a part of the study, said vaccines act as a protective factor against cardiac complications of Covid. They reduced venous thrombosis or clotting in veins by 80%, arterial clotting, which leads to heart and brain attacks, by 50% and also reduced heart failure by 50%. According to Dr Rajiv Narang, Professor and Head, Cardiology, the risk factors include smoking, which is easily preventable. 'In the maximum number of heart attack cases where we have to conduct angioplasty, smoking was the most common factor. The other risks are diabetes, high blood pressure and high cholesterol, psychosocial stress which leads to abnormal hormone release, and abdominal obesity. Protective factors include exercising regularly and consuming fruits and vegetables,' he said. In the next part of the ongoing study, a molecular-level analysis will be done to find any connection between vaccines and deaths. 'We will analyse any mutation or variation on the molecular level, if any,' said Dr Arava.
Time of India
an hour ago
- Time of India
Govt Reaffirms COVID Vaccine Safety as Private Hospitals Stay Quiet—Raising Questions
New Delhi: As concerns about sudden cardiac deaths among young adults continue to make headlines, the Indian government and top pharmaceutical voices have reiterated that COVID-19 vaccines are safe, effective, and not linked to heart-related fatalities. However, a curious silence from leading private hospitals and senior doctors—who played a central role in the nationwide vaccination drive—is beginning to raise questions about transparency and public engagement. Private hospitals, which were deeply involved in the vaccination rollout, remaining silent at this juncture cannot be taken lightly. This silence is not necessarily an admission of doubt, but the absence of their voice in the public domain—especially when scientific clarity is most needed—has not gone unnoticed. Health authorities maintain that India's vaccines have undergone rigorous testing and regulatory scrutiny. Dr. G.V.J.A. Harshavardhan, Director General of the Indian Vaccine Manufacturers Association, in an official statement, reaffirmed:'COVID-19 vaccines of India were developed and manufactured with the highest safety and quality standards. Patient safety and product quality are always prioritized during the vaccine development and its manufacture.' He added that all vaccines were approved for Emergency Use Authorization (EUA) based on extensive preclinical and clinical trials demonstrating safety, efficacy, and immunogenicity. 'Prior to their release, all COVID-19 vaccines are tested extensively for safety by the manufacturers and are also provided Batch Release Certification by the Central Drugs Laboratory (CDL), Kasauli, Himachal Pradesh, of the Ministry of Health and Family Welfare,' he said. 'The strengths of innovation and large-scale high-quality manufacturing are the hallmarks of the Indian vaccine ecosystem.' India's Global Vaccine Leadership During the pandemic, India supplied vaccines to over 90 countries under its Vaccine Maitri initiative. Officials cite this as proof of international confidence in Indian-made vaccines. Sudarshan Jain, Secretary General of the Indian Pharmaceutical Alliance, echoed this sentiment and raised concerns about the harmful impact of misinformation. 'The Indian pharmaceutical industry is a knowledge-driven sector and plays a vital role in global health. India accounts for 60 per cent of global vaccine production. These vaccines have been well documented and rigorously tested as per regulatory processes,' he said. 'Misinformation and distortion of facts endanger public health and undermine the trust built on science and patient care globally.' Private Hospitals, Key Vaccination Partners, Maintain Silence as Questions Mount Despite these strong assurances, prominent private hospitals and top medical experts associated with them have largely refrained from commenting on the rising concerns related to post-vaccination adverse events . ETHealthworld reached out to several hospital networks involved in mass immunization, but most declined to comment or said they had no official position at this time. This silence is puzzling. These institutions were once highly vocal during the vaccine rollout, actively conducting drives, issuing FAQs, and promoting vaccine awareness. Their muted response today, amid public anxiety, is being seen as a missed opportunity to educate and reassure. 'We're not blaming hospitals,' said a senior public health expert, 'but their absence in this conversation is noticeable. If the data supports vaccine safety—as government and pharma leaders insist—then trusted medical institutions should lead from the front, explaining how adverse events are monitored and managed. Silence only deepens doubt.' Experts say the role of private hospitals is critical not just in vaccine delivery, but in reinforcing public trust. With vaccine hesitancy rising globally, communication gaps—especially from frontline players—risk allowing misinformation to fill the void. Why Transparency Now Matters More Than Ever? In an age where misinformation travels faster than facts, silence can be dangerous. Transparency—even when dealing with rare or uncomfortable adverse events—is essential to preserving long-term confidence in scientific interventions. India's COVID-19 vaccination program has been widely praised for its scale and speed. But success in public health doesn't end with delivery—it continues through open dialogue, education, and the courage to confront evolving narratives head-on. As the debate around vaccine safety intensifies, it is essential that all stakeholders—government bodies, pharmaceutical leaders, and healthcare institutions—participate in a unified, fact-based public conversation. Rebuilding and reinforcing public trust isn't just a policy goal. It's a shared responsibility.
